Heparanase is a predictive marker for high thrombus burden in patients with ST-segment elevation myocardial infarction.
Conclusion: Elevated HPA level in patients with STEMI is related to high TB. Furthermore, increased HPA level may be associated with thrombotic complications such as no-reflow phenomenon in patients with STEMI.
PMID: 31215255 [PubMed - as supplied by publisher]
Source: Biomarkers - Category: Research Tags: Biomarkers Source Type: research
More News: Angiography | Angioplasty | Coronary Angioplasty | Heart Attack | Percutaneous Coronary Intervention | Research | Study | Thrombosis